"10.1371_journal.pone.0130439","plos one","2015-06-18T00:00:00Z","Franck Maunoury; Anastasiia Motrunich; Maria Palka-Santini; St√©phanie F Bernatchez; St√©phane Ruckly; Jean-Fran√ßois Timsit","Statesia, Le Mans, France; 3M Company, Neuss, Germany; 3M Company, St. Paul, United States of America; Grenoble University Hospital, Grenoble, France; IAME UMR1137-Team 5 Decision Sciences in Infectious Disease Prevention, Control and Care, Paris Diderot University-Inserm, Sorbonne Paris Cit√©, Paris, France; Paris Diderot University‚ÄBichat University hospital‚ÄMedical and Infectious Diseases Intensive care unit, Paris, France","Conceived and designed the experiments: FM AM. Performed the experiments: FM AM. Analyzed the data: FM AM. Contributed reagents/materials/analysis tools: FM AM SR JFT. Wrote the paper: FM AM. Contributed to reviewing the manuscript, as well as to the presentation of the figures and tables: MPS. Critically reviewed the draft of the manuscript for contents and clarity and for data interpretation, contributed to manuscript reviewing and editing, as well as to the presentation of the figures and tables, and the discussion: SFB.","This study was funded by 3M Company, http://solutions.3mdeutschland.de/wps/portal/3M/de_DE/EU2/Country/. MPS and SFB are employees of 3M Company and had a role in preparation of the manuscript. 3M Tegaderm CHG is a product marketed by 3M Company. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","06","Franck Maunoury","FM",6,TRUE,2,2,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
